Skip to main content
. 2024 Jul 5;16(7):903. doi: 10.3390/pharmaceutics16070903

Figure 9.

Figure 9

Antibacterial activity of the tested samples against (a) S. aureus, (b) E. coli, and (c) P. aeruginosa: 1—β-CDLA/ENR 1/1, 2—β-CDLA/ENR 2/1, 3—β-CDLA nanofibers, 4—ENR, 5—water/DMSO (3/1 v/v), 6—ciprofloxacin.